Brentwood, TN, May 21, 2024: Global healthcare supplier BDSC Company, along with CorDx, one of the largest medical device distributors in the country, is proud to announce a breakthrough in the rapid test diagnostic medical industry sector. CorDx recently received Emergency Use Authorization (EUA) for its CorDx Tyfast Flu A/B & COVID-19 At Home Rapid Test, which BDSC will distribute in North America.
The 3-in-1 self-test is a lateral flow immunoassay device intended for the qualitative detection and differentiation of nucleocapsid protein antigens from influenza type A and type B as well as SARS-CoV-2. A sample is collected with one shallow nasal swab from those suspected of respiratory viral infection. This new at-home diagnostic solution sets the standard for detecting and distinguishing between Flu A, Flu B, and COVID-19 in just 10 minutes.
At-home testing provides rapid results from the comfort of home, especially as respiratory viruses surge. The next generation of at-home tests gives consumers more efficient yet comparable diagnostic accuracy to laboratory-based testing. CorDx’s high-performance test has been authorized for in-vitro diagnostic use under EUA but has not been FDA-cleared or approved.
“This test is truly a game changer for every household. The ability to accurately test for Flu A, Flu B, and COVID with a single shallow nasal swab in a few short minutes gives every individual the control to determine their next step regarding their personal care. We could not be more excited to align with the CorDx team to bring this product to the US Market,” said Richard Doughty, President/CEO of BDSC.
BDSC has the CorDx 3-in-1 self-test in its Memphis, TN warehouse, and is ready to ship today.
About CorDx:
CorDx, a global biotechnology organization, is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing footprints in the United States and around the world. CorDx develops, manufactures, and distributes diagnostics and related tools that empower users to monitor and improve their health. Its proprietary diagnostic solutions are recognized by families and medical professionals for being affordable, user-friendly, and precise.
About BDSC:
BDSC is a privately held, US-based, global healthcare company headquartered in Brentwood, TN. BDSC Company is committed to bringing clinical innovation & financial impact into the healthcare and retail markets domestically and abroad. For complete information, visit https://www.bdsccompany.com/
If you’d like more information, to become a distributor, or to place an order, please call 800-592-1041.
Media Contact:
BDSC Company
Attn: Media Relations
5300 Maryland Way, Ste. 306
Brentwood, TN 37027
info@BDSCcompany.com
